Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL518099 | 0.87 | POLB (0.33) | TSHRTDP1 | |
| SCHEMBL19880109 | 0.84 | POLB (0.32) | — | |
| SCHEMBL156987 | 0.84 | TSHR (0.43) | TSHRTDP1 | |
| SCHEMBL27119879 | 0.78 | — | — | |
| SCHEMBL19880108 | 0.78 | TSHR (0.35) | TSHRTDP1 | |
| SCHEMBL25567317 | 0.78 | ALDH1A1 (0.35) | — | |
| SCHEMBL16260551 | 0.78 | — | — | |
| SCHEMBL3431415 | 0.75 | POLB (0.31) | — | |
| SCHEMBL15759764 | 0.74 | LMNA (0.30) | — | |
| SCHEMBL12694198 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023225631-A1 | INTERCALATING SUGAR MOLECULES | XALUD THERAPEUTICS, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| EP-2760958-B1 | SYSTEMS, METHODS AND COMPOSITIONS FOR PRODUCTION OF TIE-LAYER ADHESIVES | EQUISTAR CHEM LP (US) | 2020-08-12 | — | — | EP | disclosed |
| US-10557128-B2 | PSMA binding ligand-linker conjugates and methods for using | PURDUE RESEARCH FOUNDATION (US) | 2020-02-11 | — | — | US | disclosed |
| EP-2673315-B1 | POLYETHYLENE FILMS | EQUISTAR CHEM LP (US) | 2019-03-20 | — | — | EP | disclosed |
| US-20190002861-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION (US) | 2019-01-03 | — | — | US | disclosed |
| EP-1943281-B1 | HYBRID CATALYST SYSTEMS SUPPORTED ON MAGNESIUM HALIDE | BASELL POLYOLEFINE GMBH (DE) | 2017-09-20 | — | — | EP | disclosed |
| US-9676971-B2 | Systems, methods and compositions for production of tie-layer adhesives | EQUISTAR CHEMICALS, LP (US) | 2017-06-13 | — | — | US | disclosed |
| EP-2513166-B1 | PROCESS FOR THE PREPARATION OF SUPPORTED CATALYSTS | BASELL POLYOLEFINE GMBH (DE) | 2017-04-05 | — | — | EP | disclosed |
| US-20160222257-A1 | SYSTEMS, METHODS AND COMPOSITIONS FOR PRODUCTION OF TIE-LAYER ADHESIVES | EQUISTAR CHEMICALS, LP (US) | 2016-08-04 | — | — | US | disclosed |
| US-9321945-B2 | Systems, methods and compositions for production of tie-layer adhesives | EQUISTAR CHEMICALS, LP (US) | 2016-04-26 | — | — | US | disclosed |
| WO-2006063826-A1 | MONOCYCLOPENTADIENYL COMPLEXES | BASELL POLYOLEFINE GMBH (DE) | 2006-06-22 | — | — | WO | disclosed |
| WO-2006018264-A2 | CYCLOPENTADIENYL COMPLEXES OF GROUP 6 SUBSTITUTED BY SILYL HALIDES | BASELL POLYOLEFINE GMBH (DE) | 2006-02-23 | — | — | WO | disclosed |
| US-20060004215-A1 | Monocyclopentadienyl complexes | EQUISTAR CHEMICALS, LP | 2006-01-05 | — | — | US | disclosed |
| WO-2005103100-A1 | POLYETHYLENE AND CATALYST COMPOSITION FOR ITS PREPARATION | BASELL POLYOLEFINE GMBH (DE) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005103096-A1 | POLYETHYLENE FOR INJECTION MOLDINGS | BASELL POLYOLEFINE GMBH (DE) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005058983-A2 | MONOCYCLOPENTADIENYL COMPLEXES | BASELL POLYOLEFINE GMBH (DE) | 2005-06-30 | — | — | WO | disclosed |
| EP-1539774-A1 | MONOCYCLOPENTADIENYL COMPLEXES | Basell Polyolefine GmbH (DE) | 2005-06-15 | — | — | EP | disclosed |
| US-20040147413-A1 | IMS detection of chemical markers in petroleum products | AUTHENTIX, INC. | 2004-07-29 | — | — | US | disclosed |
| WO-2004018489-A1 | MONOCYCLOPENTADIENYL COMPLEXES | BASELL POLYOLEFINE GMBH (DE) | 2004-03-04 | — | — | WO | disclosed |
| US-6328943-B1 | CONTACTING IRON SULFIDES AND/OR PRECURSORS THEREOF IN THE PRESENCE OF AIR WITH AN EFFECTIVE INHIBITING AMOUNT OF A TREATMENT COMPOUND SELECTED FROM AMINE, ALCOHOL, KETONE, OR MIXTURES | BETZDEARBORN INC. | 2001-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10557128-B2 | PSMA binding ligand-linker conjugates and methods for using | FOLH1, KLK3, PSMA1 | TSHR 3030/4885TDP1 4183/4885 |
| US-20060004215-A1 | Monocyclopentadienyl complexes | CDV3, PCBP1, PPOX | TSHR 4197/4885TDP1 3405/4885 |
| US-20190002861-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | TSHR 3030/4885TDP1 4183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.